Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in preventing acetaminophen's interference effect on glucose sensing.

Key facts

Study ID

NCT03087877

Run by

DexCom, Inc.

People needed

70

Starts

2017-02-03

Expected to finish

2017-03-04

Last updated by the study team

2018-12-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 18 or older
• Diagnosis of diabetes

You may not qualify if…

• Pregnancy
• Known gastroparesis
• Abnormal liver function

Where it is running

• AMCR — Escondido, California, United States
• William Sansum Diabetes Center — Santa Barbara, California, United States
• Diablo Clinical Research — Walnut Creek, California, United States
• Rainier Clinical Research Center Inc — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.